Sign inJoin waitlistJoin the waitlist

John Ciotti

Assistant Program Director, MS Fellowship · University of South Florida Morsani College of Medicine

Credentials: · · · ·

History

MS Fellowship · University of South Florida Morsani College of Medicine
Present
Multiple Sclerosis/Neuroimmunology Fellowship · University of South Florida Morsani College of Medicine
Present
University of South Florida Morsani College of Medicine
Present

University of Washington School of Medicine
2018–2019
Neurology
Washington University/B-JH/SLCH Consortium
2016–2018
Barnes-Jewish Hospital
2015–2016
Charles E. Schmidt College of Medicine
2011–2015
Biology, University of Florida, 2010
2006–2010

Research

Effects of MS disease-modifying therapies on responses to vaccinations: A review
Review · Multiple Sclerosis and Related Disorders · 2020 · First of 3 authors · Corresponding · 104 citations
Disease-Modifying Treatment in Progressive Multiple Sclerosis
Review · Current Treatment Options in Neurology · 2018 · First of 2 authors · 55 citations
Clinical and laboratory features distinguishing MOG antibody disease from multiple sclerosis and AQP4 antibody-positive neuromyelitis optica
Multiple Sclerosis and Related Disorders · 2020 · First of 6 authors · Corresponding · 39 citations

Anne Cross
7 papers
Salim Chahin
5 papers
RN
Robert Naismith
4 papers
Brandon Moss
3 papers
Gregory Wu
3 papers
Matthew Brier
3 papers · 1 as a resident
Noah Eby
2 papers · 2 as a resident
Amjad Samara
1 paper · 1 as a resident
AK
Amy Kunchok
1 paper
Derrick Robertson
1 paper
Elena Grebenciucova
1 paper
EM
Ellen Mowry
1 paper

Clinical trials

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Site PI · Recruiting · Phase 3
Novartis Pharmaceuticals
2025–2034
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
Site PI · Recruiting · Phase 3
Novartis Pharmaceuticals
2025–2031